2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: Results of a multicentric experience

Annals of Hematology

Volumn 73, Issue 2, 1996, Pages 79-84

  Brugiatelli, M ^a   Holowiecka, B ^b   Dmoszynska, A ^c   Krieger, O ^d   Planinc Peraica, A ^e   Labar, B ^f   Callea, V ^a   Morabito, F ^a   Jaksic, B ^e   Holowiecki, J ^b   Lutz, D ^d  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b UNIVERSITY OF SILESIA   (Poland)

^c University of Lublin   (Poland)

^d ELISABETHINEN HOSPITAL   (Austria)

^e University of Zagreb   (Croatia)

^f KBC Zagreb   (Croatia)

Author keywords

2 CDA; Chronic lymphocytic leukemia; Drug efficacy; Drug toxicity; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLADRIBINE; PURINE DERIVATIVE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD TOXICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOXICITY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INFECTION COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE MARROW; CLADRIBINE; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, B-CELL, CHRONIC; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TIME FACTORS;

EID: 0029783496     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050205     Document Type: Article

References (26)

1. Piro LD, Carrera CJ, Carson DA, Beutler E (1990) Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322:1117-1121
2. Piro LD, Carrera CJ, Beutler E, Carson DA (1988) 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 72:1069-1073
3. Juliusson G, Liliemark J (1993) High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol 11:679-689
4. Delannoy A, Ferrant A, Martiat P, Montfort L, Doyen C, Sokal G, Michaux Jl (1994) 2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukemia. Nouv Rev Fr Hematol 36:311-315
5. Tallman MS, Hakimian D, Zanzig C, Hogan DK, Rademaker A, Rose E, Variakajis D (1995) Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol 13:983-988
6. Dimopoulos MA, Kantarjian H, Webwe D, O'Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R (1994) Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694-2698
7. Kay AC, Saven A, Carrera CJ, Carson DA, Thurston D, Beutler E, Piro LD (1992) 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol 10:371-377
8. Hoffman M, Tallman MS, Hakimian D, Janson D, Hogan D, Variakagis D, Kuzel T, Gordon LI, Rai K (1994) 2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma. J Clin Oncol 12:788-792
9. Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD (1992) 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma. Blood 80:587-592
10. Vahdat L, Wong ET, Wile MJ, Rosenblum M, Foley KM, Warrell RP (1994) Therapeutic and neurotoxic effect of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. Blood 84:3429-3434
11. Leonard RFC, Haynard RL, Prescott RJ, et al (1991) The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma. Ann Oncol 2:665-667
12. Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311:1471-1475
13. Montserrat E, Rozman C (1988) Prognostic factors in chronic lymphocytic leukemia. In: Polliack A, Catovsky D (eds) Chronic lymphocytic leukemia. Harwood Academic, London, pp 111-118
14. Rozman C, Montserrat E (1989) Chronic lymphocytic leukemia: when and how to treat. Blut 59:467-474
15. Brugiatelli M, Jaksic B, Planinc-Peraica A, Kusec R, Ostojic S, Callea V, Iacopino P, Morabito F, Stelitano C, Lutz D (1995) Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trial. Eur J Hematol 55:158-163
16. French Cooperative Group on CLL (1994) Comparison of fludarabine (FDB), CAP and CHOP in previous untreated stage B and C chronic lymphocytic leukemia (CLL). First interim results of a randomized clinical trial in 247 patients. Blood 84[Suppl 1]:461a
17. Harris NL, Jaffe ES, Stein H, Banks PM, Chen JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogen TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri S, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392
18. Jaksic B, Vitale B (1981) Total tumor mass score (TTM): a new parameter in chronic lymphocytic leukemia. Br J Hematol 49:401-413
19. Guchelaar HJ, Richel DJ, Schaafsma MR (1994) Clinical and toxicological aspects of the antineoplastic drug cladribine: a review. Ann Hematol 69:223-230
20. Saven A, Emanuele S, Kosty M, Koziol J, Ellison D, Piro L (1995) 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. Blood 86:1710-1716
21. Saven A, Lemon RH, Kosty M, Beutler E, Piro LD (1995) 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. J Clin Oncol 13:570-574
22. Delannoy A, Martiat P, Gala Jl, Deneys V, Ferrant A, Bosly A, Scheiff JM, Michaux JL (1995) 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL). Leukemia 9:1130-1135
23. Seymour JF, Kurzrock R, Freireich EJ, Estey EH (1994) 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte count in patients with hairy cell leukemia. Blood 83:2906-2911
24. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine. Blood 81:143-150
25. Zinzani PL, Tosi P, Visani G, Martinelli G, Farabegoli P, Buzzi M, Ottaviani E, Salvucci M, Bendandi M, Zaccaria A, Tura S (1994) Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells. Am J Hematol 47:301-306
26. Morabito F, Callea I, Rodino' A, Messina G, Callea V, Iacopino P, Nobile F, Brugiatelli M (1995) Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia. Leukemia 9:1450-1455